shortage semaglutide Out of Shortage, Into Controversy: The Fight Over GLP-1 Compounding Semaglutide Shortage Over? The FDA's

Hims & Hers failed to fully wind down its compounded semaglutide business and was sued by Novo Nordisk for patent infringement in February 2026 after it attempted to sell a compounded version of Novos newly approved Wegovy pill

These may consist of abdominal discomfort or pain, which can be bloating or cramping, and back pain that is usually found as a dull ache

Consuming more than one medium overripe banana can elevate blood sugar levels, particularly when not balanced with fats or proteins, Routhenstein cautions

it has been hypothesised to complement GLP-1 activity, though evidence in humans remains limited